During the past 3 years, the average Book Value per Share Growth Rate was 38.10% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 26.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Provectus Biopharmaceuticals was 39.40% per year. The lowest was -41.20% per year. And the median was -24.30% per year.
Competitive Comparison of Provectus Biopharmaceuticals's 3-Year Book Growth Rate
For the Biotechnology subindustry, Provectus Biopharmaceuticals's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Provectus Biopharmaceuticals's 3-Year Book Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Provectus Biopharmaceuticals's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Provectus Biopharmaceuticals's 3-Year Book Growth Rate falls into.
Provectus Biopharmaceuticals 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
Provectus Biopharmaceuticals (OTCPK:PVCT) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Provectus Biopharmaceuticals 3-Year Book Growth Rate Related Terms
Thank you for viewing the detailed overview of Provectus Biopharmaceuticals's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Provectus Biopharmaceuticals (Provectus Biopharmaceuticals) Business Description
Provectus Biopharmaceuticals Inc is a is a clinical-stage biotechnology company. It is engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The company has developed and intends to license or market and sell its two prescription drug candidates, PV-10 and PH-10. Its PV-10 is for the treatment of several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The PH-10 is to provide minimally invasive treatment of chronic severe skin afflictions such as psoriasis and atopic dermatitis, a type of eczema.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PVCT has been successfully added to your